Aricept - Donepezil

What is it?

Composition

Donepezil hydrochloride (donepezil, donepezil HCl) is the active pharmaceutical ingredient in Aricept. It belongs to the cholinesterase inhibitor class and is designed to increase acetylcholine signalling in the central nervous system. This is why it is used for dementia symptoms in Alzheimer’s disease rather than for depression, pain, or sleep disorders.

How to use?

Aricept is taken by mouth as tablets. The usual pattern is a gradual dose increase (titration) to improve tolerability.

Typical administration used in practice:

• Start: 5 mg once daily, often at bedtime.
• Increase: after 4–6 weeks, the dose can be increased to 10 mg once daily at bedtime if tolerated.
• Food: can be taken with or without food.

Common patient mistakes

• Rushing the dose increase. Jumping from 5 mg to 10 mg too soon is a common reason for nausea, dizziness, and stopping the medicine.
• Ignoring low pulse symptoms. Unusual fatigue, light-headedness when standing, or near-fainting can signal bradycardia (slow heart rate) in susceptible patients.
• Mixing with “night-time cold” products. Some OTC sleep/cold medicines have anticholinergic effects that can blunt the cognitive benefit and worsen confusion.
• Stopping abruptly after a bad week. A short spell of GI upset can settle; stopping and restarting repeatedly can make side effects feel worse.
• Not tracking weight and appetite. Weight loss can sneak up over a month, especially in frail older adults.

How does it work?

• Oral tablets: take 5 mg once daily at bedtime; swallow with water.
• Dose adjustment: after 4 to 6 weeks, the dose may be increased to 10 mg once daily if tolerated.
• Maximum routine dose: 10 mg once daily.
• Administration with food: take with or without meals; if stomach upset occurs, take it after a meal.
• Duration: take every day for as long as prescribed; do not stop or change the dose without medical advice.
• Route: oral (tablets).

Indications

Aricept is prescribed for adults diagnosed with Alzheimer’s disease–related dementia, mainly in mild Alzheimer’s disease and moderate Alzheimer’s disease. Most patients are elderly, yet “elderly” is not a dose by itself—tolerability, weight, heart rate, and other medicines often matter more than age alone.

Aricept is used for cognitive symptoms (memory, orientation, attention) and can also help some behavioural symptoms linked to dementia. People with severe dementia in Alzheimer’s disease may still be treated in some care plans, though response rates can be lower and side effects can become limiting.

Comparison

Treatment choices for Alzheimer’s-related dementia are usually based on symptom profile, tolerability, and comorbidities like bradycardia or frailty. Aricept is one of several cognitive enhancers used in dementia care.

Doctors often start with a cholinesterase inhibitor like donepezil when the diagnosis is mild to moderate Alzheimer’s disease and daily tasks are slipping. Memantine is more often added later when symptoms are moderate to severe, or when cholinesterase inhibitors are not tolerated.

Contraindications

Aricept should not be used in:

• Allergy or hypersensitivity to donepezil or tablet excipients
• Significant cardiac conduction problems such as sick sinus syndrome, or a history of unexplained fainting linked to bradycardia

Not recommended for

Aricept is not a good fit if you have certain heart rhythm problems, a history of fainting, or a known allergy to donepezil. Extra care is also needed if you have stomach bleeding risks, asthma, COPD, are very frail, or become dehydrated easily. If you take several medicines, a full medication review can help lower the risk of falls, fainting, or confusion.

Side effects

Most side effects are dose-related and appear early, often during initiation or after a dose increase. Many ease over 1–3 weeks, but some require a dose reduction or stopping.

Common side effects reported with donepezil include:

• Nausea, diarrhoea, vomiting
• Reduced appetite and weight loss
• Headache, dizziness, fatigue
• Sleep disturbance, vivid dreams

Less common but clinically important effects:

• Slow heart rate (bradycardia), fainting, or conduction problems in vulnerable patients
• Stomach or duodenal ulcer / GI bleeding risk (higher if combined with NSAIDs)
• Muscle cramps
• Worsening asthma or COPD symptoms in sensitive individuals

Common mistakes

• Rushing the dose increase. Jumping from 5 mg to 10 mg too soon is a common reason for nausea, dizziness, and stopping the medicine.
• Ignoring low pulse symptoms. Unusual fatigue, light-headedness when standing, or near-fainting can signal bradycardia (slow heart rate) in susceptible patients.
• Mixing with “night-time cold” products. Some OTC sleep/cold medicines have anticholinergic effects that can blunt the cognitive benefit and worsen confusion.
• Stopping abruptly after a bad week. A short spell of GI upset can settle; stopping and restarting repeatedly can make side effects feel worse.
• Not tracking weight and appetite. Weight loss can sneak up over a month, especially in frail older adults.

Doctor opinions

Prescribers usually frame Aricept as a “function-supporting” medicine, not a cure. The best candidates tend to be patients whose main problem is memory and attention drift rather than severe agitation, since cognitive benefit is easier to see than behavioural change.

A pattern I’ve seen: families report the clearest benefit when they pair Aricept with consistent routines—same wake time, structured meals, and simple one-step instructions—because the drug improves signal transmission, yet the environment still needs to be predictable. Another clinical reality is that side effects drive discontinuation more than lack of benefit, so slow titration and early follow-up calls can make the difference between continuing and stopping.

NICE guidance on dementia care supports the use of acetylcholinesterase inhibitors, including donepezil, for managing mild to moderate Alzheimer’s disease symptoms when appropriate for the individual patient. ^[5]

Frequently asked questions

Can Aricept be used for other types of dementia?

Aricept is primarily indicated for dementia due to Alzheimer’s disease, and evidence varies across other dementia types. In mixed dementia, clinicians may still consider donepezil when Alzheimer’s pathology is suspected, but response can be less predictable. NICE guidance (2022) focuses donepezil use on Alzheimer’s disease rather than routine use across all dementias. Treatment choice is usually based on diagnosis, symptom pattern, and tolerability.

Time to noticeable effects

Aricept tends to work gradually, so families often judge it over weeks rather than days. Many clinicians reassess benefit after the patient has been stable on a dose for several weeks, since early side effects can mask improvement. The EMA SmPC for donepezil describes symptomatic benefit and supports a titration period before judging response. A practical expectation is “small functional gains or slower decline,” not a sudden turnaround.

Alcohol use

Alcohol can worsen dizziness, sleep disturbance, and confusion in dementia, which can make Aricept tolerability harder. It can also increase fall risk, a key safety issue in older adults. WHO dementia care guidance highlights avoiding triggers that worsen cognition and balance, and alcohol is a common one. If alcohol is used at all, many clinicians suggest keeping it minimal and consistent so changes in cognition are easier to interpret.

Tablet splitting or crushing

With Aricept tablets, splitting is sometimes done for swallowing support if the tablet is scored and the prescribed dose remains accurate, while crushing can increase bitterness and reduce adherence. Swallowing difficulty in dementia is common, so doctors often look for practical solutions like taking with soft food (when appropriate) or changing timing. The safest approach is to match the method to the patient’s swallowing assessment and dosing plan rather than improvising. The EMA product information for donepezil provides the reference point for administration considerations.

What monitoring matters most in the first month

Pulse, weight, hydration status, and sleep are the four checks that catch most early problems. A low pulse with dizziness is a red flag for bradycardia-related intolerance. Weight loss can appear quietly and becomes harder to reverse in frail patients. NICE dementia guidance supports regular review of benefit versus adverse effects when cholinesterase inhibitors are started.

Do you offer anonymous delivery?

Front view

Side view

Back view

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.